TNNT2 and COVID-19: Patients treated in the ICU experienced a greater decrease in hs-cTnT to 3 months after COVID-19 compared to those treated in the medical ward: -65% (-88% to -47%) vs. -15% (-28% to + 1% %), P < 0.001 (Fig. 2, Suppl.